abstract |
A pharmaceutical composition of albumine-free botulinum toxin derived from blood, comprising a botulinum toxin, sodium chloride or water and a polysaccharide such as hydroxyethyl starch and / or an amino acid, the pharmaceutical composition being suitable for therapeutic administration to a therapeutic human patient Alternatively, the polysaccharide and amino acid can be replaced by recombinant albumin. |